Metraipolis › archive › dc_fea996beb40c

miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5 — Europe PMC PMID:41317550

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41317550
DOI
10.1016/j.bjorl.2025.101739
License (as archived)
solo-consultazione
Archived
2026-11-08T04:47:07.206Z
SHA-256 of the archived text
045f8f64c7ff851b1dd546f11f9c6941d323f79cf4458d3fcb70420d72ca34f6
Stable URL of this page
https://metraipolis.com/documento/dc_fea996beb40c

How to cite

miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5 — Europe PMC PMID:41317550 — Europe PMC (en), https://europepmc.org/article/MED/41317550 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea996beb40c (Metraipolis archive dc_fea996beb40c, sha256 045f8f64c7ff851b1dd546f11f9c6941d323f79cf4458d3fcb70420d72ca34f6)
BibTeX
@misc{dcfea996beb40c,
  title = {miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5 — Europe PMC PMID:41317550},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41317550},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea996beb40c; sha256 045f8f64c7ff851b1dd546f11f9c6941d323f79cf4458d3fcb70420d72ca34f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41317550. Agents can read the archived copy with the MCP tool read_document.